Ajinomoto Co., Inc. · TSE:2802

Ajinomoto — Investor Presentation (May 2018)

27 slides from Ajinomoto's investor presentation, May 10, 2018

  1. Slide 1: FY2017–2019 (for 2020) Medium-Term Management Plan: Progress and Prospects

    Ajinomoto Co., Inc. (2802) FY2017–2019 (for 2020) Medium-Term Management Plan Progress and Prospects Going Forward Takaaki Nishii President & CEO May 10, 2018

  2. Slide 2: Contents

    Contents I. FY2017–2019 (for 2020) Medium-Term Management Plan II. Growth Strategy and Structural Reform III. FY2018 Financial Strategy Reference Material Appendix: Consolidated Results FY2017 Ended March 31, 2018 FY2018 Forecast by Segment Note: Business profit (consolidated) in this material: Sale

  3. Slide 3: Contents

    Contents I. FY2017–2019 (for 2020) Medium-Term Management Plan II. Growth Strategy and Structural Reform III. FY2018 Financial Strategy Reference Material Appendix: Consolidated Results FY2017 Ended March 31, 2018 FY2018 Forecast by Segment Note: Business profit (consolidated) in this material: Sale

  4. Slide 4: Progress on the FY2017–2019 Medium-Term Management Plan

    I-1. Progress on the FY2017–2019 (for 2020) Medium-Term Management Plan FY2017 had increased sales and profit was level with the previous year, but businesses with issues were apparent. In FY2018 we will continue to expand businesses with good performance and complete the reorganization of businesse

  5. Slide 5: Factors Influencing FY2017 Business Profit (vs. forecast)

    I-2. Factors Influencing FY2017 Business Profit (vs. forecast) Exchange rate Exchange rate Average $=108.3 $=110.0 exchange rate $=110.8 (¥ Billion) Primarily write-down of 110 inventory at affiliated companies related to the 105 packaging business 0.1 0.1 -1.3 100 1.5 3.6 -3.5 0.0 95 90 102.0 Steep

  6. Slide 6: Factors Influencing FY2018 Business Profit (YoY)

    I-3. Factors Influencing FY2018 Business Profit (YoY) FY2018 forecast, FY2019 projection & plan (¥ Billion) Exchange rate Exchange rate $=110.0 $=100.0 130 +5% +12% 120 110 ・Resolution2.0 0.1 of business 5.7 -8.2 issues -0.8 7.9 ・Organic growth 100 9.0 124.0 90 116.0 97.3 Includes improvement of 103

  7. Slide 7: Profit for FY2018

    I-4. Profit for FY2018 Increased profits expected for FY2018, despite the reactionary effect of the tax revision in America in the previous year. FY18 FY17 (¥ Billion) -: losses Forecast Actual Difference Main factors Sales 1,184.0 1,150.2 33.7 FY17 actual: Share of profit of associates and joint ve

  8. Slide 8: Animal Nutrition Structural Reform Expenses

    I-5. Animal Nutrition Structural Reform Expenses Board of Directors decided on a concrete reduction plan for in-house production of animal nutrition commodities. Recorded FY2017 impairment loss of ¥7.4 billion and other structural reform expenses of ¥0.7 billion for a total of ¥8.1 billion. ◆ Full s

  9. Slide 9: Contents

    Contents I. FY2017–2019 (for 2020) Medium-Term Management Plan II. Growth Strategy and Structural Reform III. FY2018 Financial Strategy Reference Material Appendix: Consolidated Results FY2017 Ended March 31, 2018 FY2018 Forecast by Segment Note: Business profit (consolidated) in this material: Sale

  10. Slide 10: Growth Strategy: Seasonings & Processed Foods in Japan

    II-1. Growth Strategy Food Products Business: Seasonings & Processed Foods in Japan Seasonings & Processed Foods Steady sales and profit growth through creation of FY2017-2019 sales CAGR: 4% new meal scenes in major brands 1) Knorr® Continued expansion of sales of the Hot Breakfast series and “made

  11. Slide 11: Growth Strategy: Frozen Foods in Japan

    II-2. Growth Strategy Food Products Business: Frozen Foods in Japan Frozen Foods  Continue stable growth of core categories and attempt to FY2017-2019 sales CAGR: 4% create new frozen food categories capturing the changes in diet 1) Home-use • Strengthen core products and expand the top line of mai

  12. Slide 12: Growth Strategy: International Seasonings

    II-3. Growth Strategy Food Products Business: International Seasonings  Establish the world’s no. 1 seasonings, backed by Seasonings & Processed Foods FY2017-2019 sales CAGR: 6% Specialty. Create demand for menu-specific seasonings and continually expand share. 1) Flavor seasonings—thorough pursuit

  13. Slide 13: Growth Strategy: International Frozen Foods (North America)

    II-4. Growth Strategy Food Products Business: International Frozen Foods (North America)  Significant growth through Specialty products that Frozen Foods FY2017-2019 sales CAGR: 11% have improved quality and deliciousness. Quickly establish stable production that supports growth and concentrate on

  14. Slide 14: Growth Strategy: Canned Coffee, Birdy (Thailand)

    II-5. Growth Strategy Food Products Business: Canned Coffee, Birdy® (Thailand)  Stabilization of profit foundation focusing RTD *2 Market Trend in Thailand on a value strategy based on improved Qty. (1 k cases) 1.2% 0.5% quality and deliciousness for loyal users 35,000 5.5% 7.4% Value (M THB) 33,10

  15. Slide 15: Growth Strategy: Coffee Products 1

    II-6. Growth Strategy Food Products Business: Coffee Products 1 ◆ No growth for market overall. The personal market and away-from-home (restaurant and industrial-use) trend are growing. Strive to concentrate strategies on both personal and restaurant and industrial-use markets. (growth, %) (¥ bil.)

  16. Slide 16: Growth Strategy: Coffee Products 2

    II-6. Growth Strategy Food Products Business: Coffee Products 2 Coffee Products FY2017-2019 sales CAGR: 5% 1) Home-use i. Continue to grow the stick-type market over the medium- to long-term. • Enhancement of product line-up (flavor varieties) and strengthening of communication including digital met

  17. Slide 17: Growth Strategy: AminoScience Healthcare 1

    II-7. Growth Strategy AminoScience Business: Healthcare 1 Pharmaceutical Custom ◆ Pharmaceutical custom manufacturing Manufacturing From small molecule API*1 to large molecule oligonucleotides and ADC,*2 FY2017-2019 sales CAGR: 3% create highly profitable CDMO*3 business via continuous investment an

  18. Slide 18: Growth Strategy: AminoScience Healthcare 2

    II-7. Growth Strategy AminoScience Business: Healthcare 2 Healthcare Other ◆ Downstream strategy (brand + inside strategy) FY2017-2019 sales CAGR: 25% Provide health ingredients as Foods with Function Claims and as a variety of food ingredients, also expand area of operation (North America). BtoC: F

  19. Slide 19: Structural Reform: Animal Nutrition

    II-8. Structural Reform: Animal Nutrition Animal Nutrition FY2017-2019 sales CAGR: 10% In-house production ratio ◆ Animal nutrition 1) Switch lysine and threonine to OEM Incrementally reduce in-house Lysine production of lysine and threonine Threonine and replace with OEM. Aim for below 50% in-house

  20. Slide 20: Non-Financial Initiatives

    II-9. Non-Financial Initiatives *ASV: Ajinomoto Group Shared Value ASV* Value Creation Content of major initiatives Stories Progress toward FY2020 target: Exceeded ◎; In-line 〇; Below △ 1 ・Promote nutrition improvement initiatives We contribute to health and well- • In Japan, increasing presence of

  21. Slide 21: Contents

    Contents I. FY2017–2019 (for 2020) Medium-Term Management Plan II. Growth Strategy and Structural Reform III. FY2018 Financial Strategy Reference Material Appendix: Consolidated Results FY2017 Ended March 31, 2018 FY2018 Forecast by Segment Note: Business profit (consolidated) in this material: Sale

  22. Slide 22: FY2018 Financial Strategy 1

    III. FY2018 Financial Strategy 1 Based on the policies of the FY2017–2019 MTP, generate cash flow, invest for growth and provide stable shareholder returns to realize business strategy. Cash Flow Investments for Growth Shareholder Returns Operating cash flow: Payout ratio: target 30% per FY approx.

  23. Slide 23: FY2018 Financial Strategy 2: Share Repurchase

    III. FY2018 Financial Strategy 2 Decision to conduct a share repurchase to increase the level of shareholder returns and improve capital efficiency. 1. Class of shares: Common stock 2. Total number of shares to be repurchased: 25 million* (maximum) *4.39% of total shares outstanding, excluding treas

  24. Slide 24: Contents

    Contents I. FY2017–2019 (for 2020) Medium-Term Management Plan II. Growth Strategy and Structural Reform III. FY2018 Financial Strategy Reference Material Appendix: Consolidated Results FY2017 Ended March 31, 2018 FY2018 Forecast by Segment Note: Business profit (consolidated) in this material: Sale

  25. Slide 25: Roadmap to a Genuine Global Specialty Company

    II-5. Roadmap to a "Genuine Global Specialty Company" Sustainable value creation as a Become a global top 10 class company with robust business structure Genuine Global Specialty Company ¥150 bil. Global top 10 class ¥130 bil. food company level1) Sustained growth as a Become a global global top 101

  26. Slide 26: FY2018 Assumed Exchange Rate and Exchange Rate Sensitivity

    FY2018 Assumed Exchange Rate and Exchange Rate Sensitivity Assumed exchange rate (vs. JPY) * Average rate during the period FY18 FY17 Actual FY16 FY17-19 * Forecast 4Q 3Q 2Q 1Q Actual MTP USD 110.00 108.22 112.98 111.00 111.09 108.3 100.0 EUR 130.00 133.14 133.02 130.37 122.26 118.7 110.0 THB 3.28 3

  27. Slide 27:  Forward-looking statements, such as business performance forecasts, made in  This material includes

     Forward-looking statements, such as business performance forecasts, made in these materials are based on management's estimates, assumptions and projections at the time of publication. A number of factors could cause actual results to differ materially from expectations.  This material includes s

Ajinomoto — Investor Presentation (May 2018) on 6ix